Skip to Main Content

Author Details

David A Phoenix
London South Bank University
1990
152
31
PMIDPaper TitleJournal TitlePublished Year
37869970Bacterial susceptibility and resistance to modelin-5.Soft Matter2023
34656552PEGylation enhances the antibacterial and therapeutic potential of amphibian host defence peptides.Biochim Biophys Acta Biomembr2022
35609188Temporin B Forms Hetero-Oligomers with Temporin L, Modifies Its Membrane Activity, and Increases the Cooperativity of Its Antibacterial Pharmacodynamic Profile.Biochemistry2022
34091807Linearized esculentin-2EM shows pH dependent antibacterial activity with an alkaline optimum.Mol Cell Biochem2021
34329558Impacts of Metabolism and Organic Acids on Cell Wall Composition and <i>Pseudomonas aeruginosa</i> Susceptibility to Membrane Active Antimicrobials.ACS Infect Dis2021
34323184Antimicrobial Peptides with pH-Dependent Activity and Alkaline Optima: Their Origins, Mechanisms of Action and Potential Applications.Curr Protein Pept Sci2021
33247193A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy.Commun Biol2020
31790693Biophysical studies on the antimicrobial activity of linearized esculentin 2EM.Biochim Biophys Acta Biomembr2020
31051230Liposome mediated-CYP1A1 gene silencing nanomedicine prepared using lipid film-coated proliposomes as a potential treatment strategy of lung cancer.Int J Pharm2019
31358802Temporin L and aurein 2.5 have identical conformations but subtly distinct membrane and antibacterial activities.Sci Rep2019
31074477Biophysical investigation into the antibacterial action of modelin-5-NH<sub>2</sub>.Soft Matter2019
27834116Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.J Liposome Res2018
29484989An Atlas of Anionic Antimicrobial Peptides from Amphibians.Curr Protein Pept Sci2018
28249727Investigations into the potential anticancer activity of Maximin H5.Biochimie2017
26745958The effect of amidation on the behaviour of antimicrobial peptides.Eur Biophys J2016
27809281pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents.Pharmaceuticals (Basel)2016
27165406Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action.Protein Pept Lett2016
27336672Low pH Enhances the Action of Maximin H5 against Staphylococcus aureus and Helps Mediate Lysylated Phosphatidylglycerol-Induced Resistance.Biochemistry2016
24963602A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology and high-pressure homogenization.J Liposome Res2015
26241652Prediction of Peptide and Protein Propensity for Amyloid Formation.PLoS One2015
25936689The increasing role of phosphatidylethanolamine as a lipid receptor in the action of host defence peptides.Prog Lipid Res2015
25955123PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.Nanomedicine (Lond)2015
25640709The role of C-terminal amidation in the membrane interactions of the anionic antimicrobial peptide, maximin H5.Biochim Biophys Acta2015
24093888Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature.Pharm Dev Technol2014
25030320Susceptibility of sheep, human, and pig erythrocytes to haemolysis by the antimicrobial peptide Modelin 5.Eur Biophys J2014
25046254The cooperative behaviour of antimicrobial peptides in model membranes.Biochim Biophys Acta2014
24833466Investigation into the potential for hypoxic interior of neoplasms to enhance HSPA expression in glioma.Mol Cell Biochem2014
24833463Reliability of HSP70 (HSPA) expression as a prognostic marker in glioma.Mol Cell Biochem2014
24928236Sounding the death knell for microbes?Trends Mol Med2014
24861483Using sound for microbial eradication--light at the end of the tunnel?FEMS Microbiol Lett2014
24641274Thymopentin nanoparticles engineered with high loading efficiency, improved pharmacokinetic properties, and enhanced immunostimulating effect using soybean phospholipid and PHBHHx polymer.Mol Pharm2014
24728560The interaction of aurein 2.5 with fungal membranes.Eur Biophys J2014
24275450The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers.Int J Pharm2014
21922503On the selectivity and efficacy of defense peptides with respect to cancer cells.Med Res Rev2013
23841919Antimicrobial activity of aurein 2.5 against yeasts.FEMS Microbiol Lett2013
23895279A novel form of bacterial resistance to the action of eukaryotic host defense peptides, the use of a lipid receptor.Biochemistry2013
23973409A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers.Int J Pharm2013
23541668Synthetic oligoureas of metaphenylenediamine mimic host defence peptides in their antimicrobial behaviour.Bioorg Med Chem Lett2013
23228929Insights into the molecular mechanism of protein native-like aggregation upon glycation.Biochim Biophys Acta2013
23299083Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.Int J Pharm2013
22960040Aurein 2.3 functionality is supported by oblique orientated α-helical formation.Biochim Biophys Acta2013
22308196Aberrant action of amyloidogenic host defense peptides: a new paradigm to investigate neurodegenerative disorders?FASEB J2012
22796173Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.Int J Pharm2012
22782185Thermodynamic interactions of a cis and trans benzanilide with Escherichia coli bacterial membranes.Eur Biophys J2012
22893009Effect of salt on the interaction of Hal18 with lipid membranes.Eur Biophys J2012
22519529Effect of amidation on the antimicrobial peptide aurein 2.5 from Australian southern bell frogs.Protein Pept Lett2012
22617856Role of molecular architecture on the relative efficacy of aurein 2.5 and modelin 5.Biochim Biophys Acta2012
21241054Influence of C-terminal amidation on the efficacy of modelin-5.Biochemistry2011
22082130Effect of cholesterol on the membrane interaction of Modelin-5 isoforms.Biochemistry2011
19629645A theoretical analysis of secondary structural characteristics of anticancer peptides.Mol Cell Biochem2010
  • 1 - 50 of 152

Recommended Authors

University of California san francisco
Career Start Year 2015
Number of shared co-authors 0
University of Oklahoma
Career Start Year 2011
Number of shared co-authors 0
The University of Texas M.D. Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
The University of British Columbia
Career Start Year 2005
Number of shared co-authors 0
University of Gdansk
Career Start Year 2004
Number of shared co-authors 0
UT Southwestern Medical Center
Career Start Year 1997
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 1996
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 0
Monash University
Career Start Year 1994
Number of shared co-authors 0
Skaggs School of Pharmacy and Pharmaceutical Sciences.
Career Start Year 1994
Number of shared co-authors 0
Imperial College London
Career Start Year 1993
Number of shared co-authors 0
Laboratory of Microbiology-Protein Research Unit, Ghent University
Career Start Year 1993
Number of shared co-authors 0
New York University Grossman School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Heidelberg University
Career Start Year 1989
Number of shared co-authors 0
National Institute of Chemistry
Career Start Year 1988
Number of shared co-authors 0
University of Virginia
Career Start Year 1986
Number of shared co-authors 0
Aix Marseille University and CNRS
Career Start Year 1984
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1982
Number of shared co-authors 0
The University of Sheffield
Career Start Year 1982
Number of shared co-authors 0
Institut de Biotecnologia i Biomedicina, Universitat Autonoma de Barcelona
Career Start Year 1980
Number of shared co-authors 0
University of Calgary
Career Start Year 1979
Number of shared co-authors 0
Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark
Career Start Year 1978
Number of shared co-authors 0
National Centre for Cell Science, SP Pune University Campus
Career Start Year 1977
Number of shared co-authors 0
University of Technology
Career Start Year 1976
Number of shared co-authors 0
University of British Columbia
Career Start Year 1974
Number of shared co-authors 0
Stockholm University
Career Start Year 1973
Number of shared co-authors 0
Columbia University Irving Medical Center
Career Start Year 1971
Number of shared co-authors 0
Enterin Research Institute Inc.
Career Start Year 1969
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 0
university of california los angeles
Career Start Year 1963
Number of shared co-authors 0

Collaborators

Seattle Children's Hospital, University of Washington
Co-authored papers 15
University of Central Lancashire
Co-authored papers 8
Co-authored papers 7
Royal Preston Hospital
Co-authored papers 5
University of Liverpool
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Co-authored papers 1
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Co-authored papers 1
Royal Preston Hospital
Co-authored papers 1
Co-authored papers 1